Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 11, 2017
CymaBay Reports First Quarter 2017 Financial Results and Provides Corporate Update
NEWARK, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with ...
May 11, 2017
TRACON Pharmaceuticals Announces Publication in Blood of Preclinical Data Indicating Activity of TRC105 in Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
May 11, 2017
BioLife Solutions Announces Q1 2017 Financial Results
BOTHELL, Wash., May 11, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation ...
May 11, 2017
Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results
REDWOOD CITY, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Capnia, Inc. (CAPN), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...
May 11, 2017
Ohr Pharmaceutical Announces Appointment of Hon. Mike Ferguson as Chairman of the Board of Directors
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced the ...
May 11, 2017
DelMar Formalizes Collaboration with PRA Health Sciences for Phase 3 Trial of VAL-083 in Recurrent Glioblastoma Multiforme (GBM)
VANCOUVER, British Columbia and MENLO PARK, Calif., May 11, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on developing new ...
May 11, 2017
VALNEVA Reports Strong Q1 Revenue Growth and Positive EBITDA; Reaffirms Financial Guidance and Pipeline Outlook for 2017
Lyon (France), May 11, 2017 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, ...
May 11, 2017
TiGenix to present at Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas
Leuven (BELGIUM) - May 11, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory ...
May 11, 2017
Zealand Pharma discloses amylin as the biological target under their 2014 agreement with Boehringer Ingelheim
Copenhagen, May 11, 2017 - Zealand Pharma A/S ("Zealand") and Boehringer Ingelheim GmbH have demonstrated that the novel long-acting amylin analogue ZP4982 prevents the development ...
May 11, 2017
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017
SAN DIEGO, May 11, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that the Company will ...
May 11, 2017
VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor at the 20th Annual ASGCT Meeting
TEL AVIV, Israel, May 11, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today announced new preclinical data indicating that treatment with ofranergene obadenovec (VB-111) augments ...
May 11, 2017
BioTime Presents Retinal Restoration Data at ARVO
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that a poster related to the ...
May 11, 2017
Vermillion Reports First Quarter 2017 Results
AUSTIN, Texas, May 11, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for the first ...
May 11, 2017
BIOPHYTIS: First patient-in in the United States and opening of 2 clinical centers for the SARA-OBS study on Sarcopenia
PARIS, May 11, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat ageing diseases, has ...
May 11, 2017
Aimmune Therapeutics Enrolls First Patient in RAMSES (ARC007), a Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy
BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (AIMT), today announced the enrollment of its first patient in the Phase 3 RAMSES (ARC007) clinical trial of AR101 for ...
May 11, 2017
Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
May 10, 2017
Onxeo Announces Allowance of U.S. Patent for Livatag® in Hepatocellular Carcinoma
PARIS, May 10, 2017 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Paris:ONXEO) (NASDAQ Copenhagen:ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs for ...
May 10, 2017
BioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments
BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today reported financial results for the first quarter ...
May 10, 2017
Albireo Reports First Quarter 2017 Financial Results
BOSTON, May 10, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today reported ...
May 10, 2017
SciClone Reports First Quarter 2017 Financial Results
FOSTER CITY, Calif., May 10, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) today reported financial results for the quarter ended March 31, 2017. Revenues: In ...
Page 113 of 117